Methylene Chloride

Methylene Chloride

SCHEMBL6533812

Cc1cc(C=O)nn1-c1ccccc1.ClCCl

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.47
KDM4C Q9H3R0 1/20 0.44
LMNA P02545 3/20 0.43
NPY5R Q15761 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
FCGR1A P12314 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MAPT P10636 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RIPK1 Q13546 3/20 0.40
HTT P42858 2/20 0.40
NTRK1 P04629 1/20 0.40
TSHR P16473 1/20 0.40
ALDH1A1 P00352 2/20 0.40
STAT1 P42224 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
P2RX7 Q99572 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2517751 0.94 MAPK1 (0.51) MAPK1KDM4CLMNANPY5RCYP1A2
SCHEMBL2324670 0.80 MAPT (0.41) MAPK1LMNACYP1A2CYP2C19NPC1
SCHEMBL1738878 0.77 RAB9A (0.50) LMNACYP1A2CYP2C19NPC1RAB9A
SCHEMBL4254538 0.75 ALDH1A1 (0.41) MAPK1KDM4CLMNACYP1A2CYP2C19
SCHEMBL1739359 0.75 L3MBTL1 (0.47) L3MBTL1ALDH1A1
SCHEMBL2324520 0.74 CYP1A2 (0.49) LMNACYP1A2CYP2C19NPC1RAB9A
SCHEMBL964125 0.74 MAPK1 (0.66) MAPK1CYP1A2CYP2C19FCGR1ANPC1
SCHEMBL28433874 0.73 MAPK1 (0.47) MAPK1LMNANPY5RCYP1A2CYP2C19
SCHEMBL14108176 0.73 CYP1A2 (0.56) MAPK1KDM4CLMNACYP1A2CYP2C19
SCHEMBL5106402 0.73 P2RX7 (0.43) MAPK1KDM4CLMNACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005040127-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES LTD. (KR) 2005-05-06 WO disclosed